PEREGRINE VENTURES REALIZES USD 500 MILLION EXIT FROM CARTIHEAL FOLLOWING FDA APPROVAL OF IMPLANT FOR TREATMENT OF CARTILAGE AND OSTEOCHONDRAL DEFECTS USA – English USA – English April 6, 2022
Former CEO of Drug Manufacturing Company Charged with Conspiring to Defraud the FDA and Distributing Adulterated Drugs April 4, 2022
FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects March 30, 2022
U.S. Food and Drug Administration (FDA) Accepts for Priority Review Taiho Oncology’s New Drug Application for Futibatinib for Cholangiocarcinoma March 30, 2022
FDA announces recall of Similac PM baby formula after infant illnesses reported, two dead March 1, 2022
Manchin Blasts Biden’s FDA Pick, Alleges He Shares ‘A Great Deal Of Responsibility’ For The Opioid Epidemic February 15, 2022
As Dems push for N95 masks, FDA, CDC issue consumer and health warnings about the expensive single-use masks January 13, 2022
Florida Co-Owner of Clinical Trial Company Pleads Guilty to Obstructing FDA Inspection January 13, 2022
French National Charged with Making False Statements to FDA to Fraudulently Obtain Control of Pharmaceutical Product November 25, 2021
Attorney General James Leads Coalition Urging FDA to Accelerate Actions to Protect Children From Toxic Metals in Baby Food October 28, 2021
